# BBy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bby

- Industry: Medical Devices & Equipment
- Headquarters: New York, US
- Website: www.bbyworld.com
- Total disclosed funding: $3.1M
- Latest round: Seed (May 25, 2023)
- Investors on record: 5

## About

BBy, Inc., based in New York, US, specializes in innovative solutions for breast milk management in hospitals, enhancing the welfare of neonates through its proprietary technologies.BBy, Inc. focuses on developing advanced breast milk storage and administration solutions for neonatal intensive care units (NICUs). Founded in 2016 in New York, US, the company has undergone strategic developments to enhance its offerings. Led by CEO Vansh Langer, BBy has successfully closed two deals, with the most recent funding round, a Seed round of USD 3.000 mn, completed on May 25, 2023. The funding was spearheaded by Pioneer Fund and included contributions from several investors, including Y Combinator and 7G BioVentures.BBy, Inc. specializes in innovative solutions for the management, storage, and administration of breast milk in hospital settings. The company’s core offering is its proprietary condensing technology that shelf-stabilizes human milk, preserving its nutritional and immunological properties. This technology allows for the removal of unbound water from the milk, creating a condensed product that can be stored at room temperature and reconstituted with water, ensuring that it remains equivalent in quality to uncondensed milk. The end users primarily include neonatal intensive care units (NICUs) in hospitals, where the product facilitates easier and quicker milk administration to infants. The company’s solutions aim to streamline workflows for healthcare providers and improve patient outcomes. BBy operates within the United States and is poised to expand into international markets where similar healthcare challenges exist.BBy, Inc. generates revenue through direct business-to-business sales to hospitals and healthcare facilities, particularly focusing on NICUs. The company's transaction structure revolves around formal partnerships and agreements with these institutions, providing bulk orders of its shelf-stable human milk product. By eliminating the need for large freezers, BBy’s offerings lead to significant cost savings in energy and labor for hospitals. The pricing for their flagship products is structured around contracts that account for varying quantities and delivery schedules, ensuring healthcare providers receive a reliable supply of breast milk tailored to their specific needs, ultimately enhancing the efficiency of milk administration and reinforcing the company's commitment to better patient care.In May 2023, BBy, Inc. raised USD 3.000 mn in a Seed round, led by Pioneer Fund, to support its growth initiatives. The company plans to enhance its product line and expand internationally, targeting regions with similar healthcare challenges. The recent funding will be essential for launching new products designed to further optimize breast milk management and for exploring new market opportunities beyond the United States.

## Funding rounds

- Seed, May 25, 2023, $3M — Y Combinator, Pioneer Fund, Cathexis Investment Management, 7G BioVentures
- Seed, Jan 26, 2017, $0.1M — Quake Capital Partners

## Investors

- Quake Capital Partners (https://capitalatlas.ai/funds/quake-capital-partners) — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed
- Cathexis Investment Management (https://capitalatlas.ai/funds/cathexis-investment-management) — Seed
- 7G BioVentures (https://capitalatlas.ai/funds/7g-bioventures) — Seed